Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Oct 26, 2011

Premium

Bernd Brust has resigned as the president of molecular medicine at Life Technologies "in order to pursue other opportunities," the company said in a filing with the US Securities and Exchange Commission this week.

Brust has led the molecular medicine business unit since January, when it was created to help the company transition to next-gen sequencing in the clinic. He previously served as Life Tech's president of commercial operations.

Life Tech said that Brust will continue to serve as a consultant through Dec. 31 "to assist the company with various endeavors."


Sequenom has added Suber Huang to its ophthalmology advisory board. Huang is president of the American Society of Retina Specialists and has served on the steering committee for the National Eye Health Education Program.

Huang is the vice-chair and Philip F and Elizabeth G Searle professor of the department of ophthalmology and visual sciences at Case Western Reserve University and director of the Center for Retina and Macular Disease and Retinal Diseases Image Analysis Reading Center at University Hospitals Case Western.

He holds a BS from Johns Hopkins University, an MD from the Albert Einstein College of Medicine, and an MBA from the Weatherhead School of Management, Case Western Reserve University.


GenomeQuest has formed a clinical advisory board.

Heidi Rehm is a board-certified clinical molecular geneticist and assistant professor of pathology at Harvard Medical School with appointments at Brigham & Women's Hospital, Massachusetts General Hospital, and Children's Hospital Boston. She also directs the Laboratory for Molecular Medicine at the Partners HealthCare Center for Personalized Medicine.

Madhuri Hegde
is an associate professor at Emory University School of Medicine and the scientific director of the Emory Genetics Laboratory. She focuses on developing next-gen sequencing tests for rare disorders.

Shashikant Kulkarni
is the medical director of genomics and pathology services and the medical director of cytogenomics and molecular pathology at Washington University School of Medicine. He is an associate professor in the departments of pathology and immunology, pediatrics, and genetics. He oversees Wash U's CLIA-certified and CAP-accredited laboratories.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.